Full
Outline
To compare the superior processing synergistic efficacy of Thirteen-processed Cyperi Rhizoma with Xiushan characteristic processing technology, and to provide a research basis for the modern industrial improvement of regional characteristic processed TCM products.
On the basis of inheriting the unique Xiushan processing technology for Thirteen-processed Cyperi Rhizoma, multiple rat models of traditional Chinese medicine syndromes were established, including primary dysmenorrhea, threatened abortion with uterine hemorrhage, and liver depression, qi stagnation and blood stasis. The therapeutic advantages of this regional characteristic processed product were comprehensively compared with those of clinically commonly-used processed products in modern practice and representative processed varieties recorded in successive dynasties.
Thirteen-processed Cyperi Rhizoma significantly reduced the writhing times (P<0.05, P<0.01), decreased the uterine organ coefficient (P<0.05, P<0.01), and lowered serum levels of PGF2α, GnRH and LH (P<0.05) in mice with primary dysmenorrhea. It also remarkably relieved vaginal bleeding volume and reduced FSH and LH levels (P<0.05) in the rat model of threatened abortion with uterine hemorrhage. In addition, it significantly decreased whole blood high-, medium-and low-shear viscosity, plasma viscosity, as well as serum ALT and AST levels (P<0.05) in rats with liver depression, qi stagnation and blood stasis.
As an inheritance of local characteristic processing technology, Thirteen-processed Cyperi Rhizoma is insufficient in repairing substantial organic lesions. However, it presents prominent processing potentiating effects in the intervention and treatment of primary dysmenorrhea, threatened abortion with uterine hemorrhage, and liver depression, qi stagnation and blood stasis. It can be regarded as a distinctive processed medicinal material for further in-depth research and modern industrial transformation and optimization.
111
31
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
